CLEVELAND, Ohio (WKRC) - The Cleveland Clinic has released the results from its breast cancer vaccine trial's first phase. According to a Cleveland Clinic-issued statement, researchers with the ...

Cleveland Clinic Innovations, the business development and commercialization arm of Cleveland Clinic, announced the creation of a spinoff company to develop a breast cancer vaccine. The company, ...

SAN JOSE, Calif., Dec. 15, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. (ANIX) ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, ...

December 11, 2025, CLEVELAND: Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive ...

CLEVELAND — Measles cases in the U.S. are at their highest levels since 2000, and experts say lower vaccination rates here and around the world are driving the resurgence. 3News’ Senior Health ...

Chairman and CEO Dr. Amit Kumar said the company views 2026 as a “pivotal year” as it advances two clinical-stage programs: a breast cancer vaccine being developed with the Cleveland Clinic and the U.

Comprehensive Results, Supported by U.S. Department of Defense Funding, to Inform FDA Discussions and Advance Phase 2 Development Plans SAN JOSE, Calif., Sept. 22, 2025 /PRNewswire/ -- Anixa ...

The MarketWatch News Department was not involved in the creation of this content. SAN JOSE, Calif., Dec. 15, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a ...